Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of 99mTechnetium–Albumin Macroaggregates
To evaluate the incidence of extrahepatic deposition of technetium-99m–labeled albumin macroaggregates (99mTc-MAA) after pretreatment angiography, before yttrium-90 radioembolizaton (90Y-RE), and to report on technical solutions that can be used to ensure safe delivery of 90Y-microspheres in patients with initial extrahepatic deposition.
Materials and Methods
A retrospective analysis of 26 patients with primary and secondary liver malignancies, who were scheduled for treatment with 90Y-RE in our institution in 2009, was performed. The angiograms and single-photon emission computed tomography images of all patients were reviewed by an interventional radiologist and a nuclear medicine physician, respectively, to identify and localize extrahepatic deposition of 99mTc-MAA when present. Subsequently, the technical solutions were used to successfully perform 90Y-RE in these patients were evaluated and described.
Extrahepatic deposition of 99mTc-MAA was observed in 8 of 26 patients (31%). In 7 of 8 patients, a second pretreatment angiography was performed to detect the cause of extrahepatic deposition. The technical solutions to enable safe 90Y microspheres delivery included more distal placement of the microcatheter in the proper/right hepatic artery in 4 of 7 (57%) patients; (super)selective catheterization of multiple segmental branches in 2 of 7 (29%); and additional coiling of a newly detected branch in the remaining patient (14%). This was confirmed by a second MAA procedure. 90Y-RE was eventually performed in 25 of 26 (96%) patients. No procedure-related complications (<30 days) were observed.
Extrahepatic deposition of 99mTc-MAA after pretreatment angiography did occur in 8 of 26 (31%) patients. The technical solutions as presented allowed safe 90Y-RE delivery in 25 of 26 (96%) patients.
- Salem R, Thurston KG (2006) Radioembolization with yttirum-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 17:1571–1593 CrossRef
- Vente MAD, Wondergem M, van der Tweel I et al (2009) Yttrium-90 microspheres radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959 CrossRef
- Salem R, Thurston KG (2006) Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17:1425–1439 CrossRef
- Lewandowski RJ, Sato KT, Atassi B et al (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Interv Radiol 30:571–592 CrossRef
- Murthy R, Nunez R, Szklaruk J et al (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41–S55 CrossRef
- Murthy R, Brown DB, Salem R et al (2007) Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561 CrossRef
- Carretero C, Munoz-Navas M, Betes M et al (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102:1216–1220 CrossRef
- Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924 CrossRef
- Wong CY, Savin M, Sherpa KM et al (2006) Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma. Cancer Biother Radiopharm 21:305–313 CrossRef
- Jakobs TF, Hoffmann RT, Poepperl G et al (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17:1320–1330 CrossRef
- Gulec SA, Mesoloras G, Dezarn WA et al (2007) Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med 5:15–23 CrossRef
- Garin E, Rolland Y, Boucher E et al (2010) First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TeraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging 37:453–461 CrossRef
- Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23 CrossRef
- Louie JD, Kothary N, Kuo WT et al (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20(5):606–613 CrossRef
- Becker C, Waggershauser T, Tiling R, et al. (2010) C-arm computed tomography compared with positron emission tomography/computed tomography for treatment planning before radioembolization. Cardiovasc Intervent Radiol. doi:10.1007/s00270-010-9897-8
- van der Bilt JD, Borel Rinkes IH (2004) Surgery and angiogenesis. Biochim Biophys Acta 1654:95–104
- Drixler TA, Vogten JM, Ritchie ED et al (2002) Liver regeneration is an angiogenesis associated phenomenon. Ann Surg 236:703–711 CrossRef
- Hamami ME, Poeppel TD, Muller S, Heusner T et al (2009) SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 50:688–692 CrossRef
- Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of 99mTechnetium–Albumin Macroaggregates
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
CardioVascular and Interventional Radiology
Volume 34, Issue 5 , pp 1074-1079
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Hepatic malignancy
- Extra-hepatic deposition
- Technetium-Albumin macroaggregates
- Industry Sectors
- Author Affiliations
- 1. Center of Interventional Oncology and Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
- 2. Department of Nuclear Medicine, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands